Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Besat Research Center is an Iranian biotechnology and medical research organization primarily recognized for its work in vaccine development and protein engineering. The center is most notable for the development of the Noora vaccine, a recombinant protein-based vaccine designed to combat COVID-19, which received emergency use authorization in Iran. Affiliated with the Islamic Revolutionary Guard Corps (IRGC) and collaborating closely with Baqiyatallah University of Medical Sciences, the center focuses on addressing domestic public health needs through advanced biological research. Its capabilities include the design, clinical evaluation, and manufacturing of biologics and infectious disease countermeasures. The organization utilizes a recombinant protein expression platform to produce therapeutic candidates and diagnostic tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Besat Research Center.